Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Historia
454
Condiciones sociales
86
Condiciones económicas
85
Desarrollo de recursos hídricos
80
Política y gobierno
69
Indígenas de México
65
Aspectos sociales
62
Vida social y costumbres
60
Abastecimiento de agua
54
Novela española
54
Leyes y legislación
49
Crítica e interpretación
45
Historia y crítica
44
Educación
35
Cuentos uruguayos
34
Estudio y enseñanza
31
Filosofía
30
Aspectos económicos
29
Antigüedades
26
Administración municipal
24
Administración
23
Biografías
23
Otomíes
20
Descripciones y viajes
19
México
19
Política gubernamental
19
Agricultura
18
Aspectos políticos
18
Diagnóstico
18
Fuentes
18
-
8961“…Besides, histone deacetylase inhibitor (HDACi) mitigates tumor growth via targeting HIF-1α, whereas underlying mechanism still requires investigation. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8962por Gusyatiner, Olga, Bady, Pierre, Pham, Minh D T, Lei, Yvonne, Park, Jungyeon, Daniel, Roy T, Delorenzi, Mauro, Hegi, Monika E“…Finally, we showed that combining HDACi with JQ1 acts synergistically in reducing cell viability of GS-lines. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8963por Barbier, Camille, Mansour, Ali, Ismailova, Aiten, Sarmadi, Fatemeh, Scarlata, David A., Bouttier, Manuella, Zeitouni, Camille, Wang, Catherine, Gleason, James L., White, John H.“…The active form of vitamin D, 1,25-dihydroxyvitamin D (1,25D), and its analogues signal through the nuclear vitamin D receptor (VDR), a ligand-regulated transcription factor, and have been extensively investigated as anticancer agents. 1,25D and its analogs have potential in combination therapies because they exhibit synergistic activities with other anticancer agents such as histone deacetylase inhibitors (HDACi). We have developed a series of hybrid molecules that combine HDACi within the backbone of a VDR agonist and thus represent fully integrated bifunctional molecules. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8964por Liu, Xincheng, Guo, Cui, Leng, Tiandong, Fan, Zhen, Mai, Jialuo, Chen, Jiehong, Xu, Jinhai, Li, Qianyi, Jiang, Bin, Sai, Ke, Yang, Wenzhuo, Gu, Jiayu, Wang, Jingyi, Sun, Shuxin, Chen, Zhijie, Zhong, Yingqian, Liang, Xuanming, Chen, Chaoxin, Cai, Jing, Lin, Yuan, Liang, Jiankai, Hu, Jun, Yan, Guangmei, Zhu, Wenbo, Yin, Wei“…Moreover, cAMP agonist combined with HDACi also induced glioma stem cells (GSCs) to differentiate into neuron-like cells through the regulation of H3K9ac/K14ac, indicating that combined induction has the potential for recurrence-preventive application. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8965
-
8966“…This metabolite/drug interaction could be termed "self-potentiation," a feature which contributes to the overall activity of HiDAC. Asparaginase enhances these effects in a schedule-dependent fashion by lowering the cellular pool size of dCTP and consequent enhanced metabolism of ara-C. …”
Enlace del recurso
Enlace del recurso
Texto -
8967por Maes, Ken, Menu, Eline, Van Valckenborgh, Els, Van Riet, Ivan, Vanderkerken, Karin, De Bruyne, Elke“…To target these aberrations, epigenetic modulating agents, such as DNA methyltransferase inhibitors (DNMTi) and histone deacetylase inhibitors (HDACi), are under intense investigation in solid and hematological cancers. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8968por Licht, Verena, Noack, Katrin, Schlott, Bernhard, Förster, Martin, Schlenker, Yvonne, Licht, Andreas, Krämer, Oliver H., Heinzel, Thorsten“…This observation may provide an explanation for the selective toxicity of HDACi against rapidly proliferating leukemic cells.…”
Publicado 2014
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8969por Mao, Jian, Zhang, Qian, Deng, Wei, Wang, Hua, Liu, Kai, Fu, Haifeng, Zhao, Qiang, Wang, Xumin, Liu, Lin“…Conversion with inhibitors of histone deacetylases (HDACi), NaB, TSA, or VPA, further increased Rex1 expression, while decreasing expression of exogenous genes. piPSCs induced by Tet1+OSKM followed by conversion with HDACi show high pluripotency. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8970por Cortiguera, María G., García-Gaipo, Lorena, Wagner, Simon D., León, Javier, Batlle-López, Ana, Delgado, M. Dolores“…Collectively we suggest that the combination of HDACi and BRD4i should be pursued in further pre-clinical testing.…”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8971“…Surprisingly, patient's condition was improved after treatment with PD-1 inhibitor in combination with DNMTi/HDACi. Restaging PET revealed dramatically radiological response.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8972por Schäker‐Hübner, Linda, Haschemi, Reza, Büch, Thomas, Kraft, Fabian B., Brumme, Birke, Schöler, Andrea, Jenke, Robert, Meiler, Jens, Aigner, Achim, Bendas, Gerd, Hansen, Finn K.“…Subsequently, we selected the most promising “capless” HDACi and transferred its ZBG to our previously published scaffold featuring a peptoid‐based cap group. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8973“…Various molecules have been developed as HDAC inhibitors (HDACi), which have become potential antiepileptic drugs for epilepsy treatment. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8974por Dou, Xiujing, Han, Junlan, Song, Wentao, Dong, Na, Xu, Xinyao, Zhang, Wei, Shan, Anshan“…In this study, we investigated whether the histone deacetylase inhibitor (HDACi) sodium butyrate (NaB) could induce HDP expression and the mechanism underlying NaB-regulated HDP expression in PK-15 cells. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8975por Wang, Amy Y., Weiner, Howard, Green, Margaret, Chang, Hua, Fulton, Noreen, Larson, Richard A., Odenike, Olatoyosi, Artz, Andrew S., Bishop, Michael R., Godley, Lucy A., Thirman, Michael J., Kosuri, Satyajit, Churpek, Jane E., Curran, Emily, Pettit, Kristen, Stock, Wendy, Liu, Hongtao“…None were unexpected given the HiDAC/Mito regimen. Serious adverse events occurred in 6 (30%) patients; one was fatal. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8976por Escherich, Gabriele, zur Stadt, Udo, Borkhardt, Arndt, Dilloo, Dagmar, Faber, Jörg, Feuchtinger, Tobias, Imschweiler, Thomas, Jorch, Norbert, Pekrun, Arnulf, Schmid, Irene, Schramm, Franziska, Spohn, Michael, Zimmermann, Martin, Horstmann, Martin A“…The primary study objective was the minimal residual disease (MRD)- based comparative assessment of cytotoxic efficacies of clofarabine 5x40 mg/m(2) versus high-dose cytarabine (HIDAC) 4x3g/m(2), both in combination with PEG-ASP 2,500 IU/m(2) as randomized intervention in early consolidation. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8977por Su, Jianmin, Wang, Yongsheng, Li, Yanyan, Li, Ruizhe, Li, Qian, Wu, Yongyan, Quan, Fusheng, Liu, Jun, Guo, Zekun, Zhang, Yong“…Altering epigenetic status by applying histone deacetylase inhibitors (HDACi) enhances developmental potential of somatic cell nuclear transfer (SCNT) embryos. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8978“…Although the precise mechanisms by which such dietary factors mediate these effects, SCFA metabolites such as butyrate also function as histone deacetylase inhibitors (HDACi), that can act on the epigenome through chromatin remodeling changes. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8979por Blattmann, Claudia, Oertel, Susanne, Thiemann, Markus, Dittmar, Anne, Roth, Eva, Kulozik, Andreas E., Ehemann, Volker, Weichert, Wilko, Huber, Peter E., Stenzinger, Albrecht, Debus, Jürgen“…Heavy ion radiotherapy (HIT) and modern anticancer drugs like histone deacetylase inhibitors (HDACi) have shown promising effects in osteosarcoma in vitro. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8980“…Similar effects are seen with histone deacetylase inhibitors (HDACi), albeit with poorer tolerance. Here, we show that bone marrow (BM) stromal cells (HS-5) protected MPN-derived cell lines (SET-2; HEL and UKE-1) and MPN patient-derived BM cells from the cytotoxic effects of Ruxolitinib and the HDACi Vorinostat. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto